Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDEGENE LTD. vs MANKIND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDEGENE LTD. MANKIND PHARMA INDEGENE LTD./
MANKIND PHARMA
 
P/E (TTM) x - 48.4 - View Chart
P/BV x 10.9 11.0 98.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDEGENE LTD.   MANKIND PHARMA
EQUITY SHARE DATA
    INDEGENE LTD.
Mar-24
MANKIND PHARMA
Mar-24
INDEGENE LTD./
MANKIND PHARMA
5-Yr Chart
Click to enlarge
High RsNA2,375 0.0%   
Low RsNA1,241 0.0%   
Sales per share (Unadj.) Rs116.6258.0 45.2%  
Earnings per share (Unadj.) Rs15.248.5 31.3%  
Cash flow per share (Unadj.) Rs18.658.4 31.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs62.9233.2 27.0%  
Shares outstanding (eoy) m222.06400.59 55.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x07.0 0.0%   
Avg P/E ratio x037.3 0.0%  
P/CF ratio (eoy) x030.9 0.0%  
Price / Book Value ratio x07.8 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0724,164 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m16,51622,747 72.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m25,896103,348 25.1%  
Other income Rs m7632,809 27.2%   
Total revenues Rs m26,659106,156 25.1%   
Gross profit Rs m5,07825,518 19.9%  
Depreciation Rs m7613,983 19.1%   
Interest Rs m494350 141.0%   
Profit before tax Rs m4,58623,994 19.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2194,576 26.6%   
Profit after tax Rs m3,36719,418 17.3%  
Gross profit margin %19.624.7 79.4%  
Effective tax rate %26.619.1 139.4%   
Net profit margin %13.018.8 69.2%  
BALANCE SHEET DATA
Current assets Rs m17,90865,655 27.3%   
Current liabilities Rs m6,10921,197 28.8%   
Net working cap to sales %45.643.0 105.9%  
Current ratio x2.93.1 94.6%  
Inventory Days Days11897 121.3%  
Debtors Days Days91300 30.5%  
Net fixed assets Rs m6,84053,146 12.9%   
Share capital Rs m444401 110.8%   
"Free" reserves Rs m13,53392,998 14.6%   
Net worth Rs m13,97793,398 15.0%   
Long term debt Rs m3,334249 1,340.7%   
Total assets Rs m24,748118,829 20.8%  
Interest coverage x10.369.5 14.8%   
Debt to equity ratio x0.20 8,958.8%  
Sales to assets ratio x1.00.9 120.3%   
Return on assets %15.616.6 93.8%  
Return on equity %24.120.8 115.9%  
Return on capital %29.326.0 112.9%  
Exports to sales %06.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA6,495 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,2356,495 157.6%   
Fx outflow Rs m4821,649 29.2%   
Net fx Rs m9,7534,846 201.3%   
CASH FLOW
From Operations Rs m5,07721,524 23.6%  
From Investments Rs m-3,272-20,817 15.7%  
From Financial Activity Rs m-66253 -1,257.1%  
Net Cashflow Rs m1,150772 149.0%  

Share Holding

Indian Promoters % 0.0 74.9 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.0 22.3 35.9%  
FIIs % 4.8 12.4 39.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 25.1 397.9%  
Shareholders   151,440 163,854 92.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDEGENE LTD. With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on INDEGENE LTD. vs MANKIND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

INDEGENE LTD. vs MANKIND PHARMA Share Price Performance

Period INDEGENE LTD. MANKIND PHARMA S&P BSE HEALTHCARE
1-Day -2.64% -1.23% 0.67%
1-Month -2.50% -2.76% -3.33%
1-Year 11.34% 27.56% 43.33%
3-Year CAGR 3.64% 21.72% 19.82%
5-Year CAGR 2.17% 12.52% 26.27%

* Compound Annual Growth Rate

Here are more details on the INDEGENE LTD. share price and the MANKIND PHARMA share price.

Moving on to shareholding structures...

The promoters of INDEGENE LTD. hold a 0.0% stake in the company. In case of MANKIND PHARMA the stake stands at 74.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDEGENE LTD. and the shareholding pattern of MANKIND PHARMA.

Finally, a word on dividends...

In the most recent financial year, INDEGENE LTD. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MANKIND PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of INDEGENE LTD., and the dividend history of MANKIND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers(Closing)

On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.